Skip to content

CURATIVE BIOSCIENCES, INC.: 10-Q filed 2018-05-15

What CURATIVE BIOSCIENCES, INC. reported in its quarterly report filed 2018-05-15 (fiscal Q3 2018): 25 published measures, 55 facts as tagged in accession 0001493152-18-007019.

This filing

Form
10-Q (quarterly report)
Filed
2018-05-15
Fiscal period
fiscal Q3 2018
Accession
0001493152-18-007019 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CURATIVE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-03-3113,871USD
At 2017-06-302,265USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-03-31719,540USD
At 2017-06-30633,065USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-03-31-705,669USD
At 2017-06-30-630,800USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-03-31982USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-01-01 to 2018-03-31-31,982USD90
2017-07-01 to 2018-03-31-500,202USD274
2017-01-01 to 2017-03-31-4,000USD90
2016-07-01 to 2017-03-31-35,301USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-07-01 to 2018-03-31-80,126USD274
2016-07-01 to 2017-03-31-11,115USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-07-01 to 2018-03-3193,628USD274
2016-07-01 to 2017-03-3111,115USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-07-01 to 2018-03-31-12,520USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-03-31-53,662,592USD
At 2017-06-30-53,162,390USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-03-31369USD
At 2017-06-302,265USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-01 to 2018-03-31425,333USD274
2016-07-01 to 2017-03-3121,000USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-03-31-31,982USD90
2017-07-01 to 2018-03-31-500,202USD274
2017-01-01 to 2017-03-31-4,000USD90
2016-07-01 to 2017-03-31-35,301USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-03-31982USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-03-31719,540USD
At 2017-06-30633,065USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-03-31170,220USD
At 2017-06-30177,374USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-03-3112,520USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-01-01 to 2018-03-3131,982USD90
2017-07-01 to 2018-03-31500,202USD274
2017-01-01 to 2017-03-314,000USD90
2016-07-01 to 2017-03-3135,301USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-03-3119,574,695shares
At 2017-06-3015,708,030shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-03-3152,937,348USD
At 2017-06-3052,515,882USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-03-3121,796USD
At 2017-06-3019,900USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-03-3112,520USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-03-316,545USD
At 2017-06-306,545USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-01-01 to 2018-03-3131,982USD90
2017-07-01 to 2018-03-3174,869USD274
2017-01-01 to 2017-03-314,000USD90
2016-07-01 to 2017-03-3114,301USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-01-01 to 2018-03-31472USD90
2017-07-01 to 2018-03-311,896USD274
2017-01-01 to 2017-03-31712USD90
2016-07-01 to 2017-03-312,136USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-07-01 to 2018-03-31-7,153USD274
2016-07-01 to 2017-03-311,050USD274

Inspect the source

Entity
CURATIVE BIOSCIENCES, INC. / CIK 0001137005
Captured
SEC response SHA-256
fc4f9cbfd643621d86ed2b35727989036c1802405eaa55274bc8b9b1425b7760

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001137005.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))